Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
January 6, 2025Journal of Medicinal Chemistry

Discovery of 2(1H)-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

CLChunzheng LiXLXiaojing LanXLXinge Li

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/69dff7e72833447a7e255b1chttps://doi.org/10.1021/acs.jmedchem.4c01635
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure-Based Design and Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High Selectivity, Brain Penetration, and In Vivo Efficacy2024 · 10 citations
  2. 2S-adenosylmethionine in Liver Health, Injury, and Cancer2012 · 566 citations
  3. 3MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells2016 · 683 citations
  4. 4Characterization of methionine dependence in melanoma cells2023 · 11 citations